Schizophrenia Clinical Trial

Schizophrenia is a serious brain disorder affecting millions of Americans. For people diagnosed with schizophrenia, the disease can be extremely disabling, affecting the ability to think clearly, distinguish reality from fantasy, to manage emotions, make decisions, and relate to others.

It can be treated

While the causes of schizophrenia remain unknown, its symptoms can be treated.

Several new medications can help you function better in your day to day life, with minimal side effect risk.

Schizophrenia Clinical Trial

Eligibility

Overview

A nationwide clinical study is screening volunteers diagnosed with schizophrenia for participation in a study to further investigate an already FDA approved investigational medication.

If you are a caregiver of someone with schizophrenia, this study may provide an opportunity for them to contribute to important research being performed to identify future treatments of this challenging condition.

Participants are usually allowed to continue their own medications for sleep or anxiety
Minimal side effect risk

Qualification Criteria

For teenagers and adults, must be between the ages of 12 and 55
Be diagnosed with schizophrenia
Be psychologically stable enough to be treated in an outpatient setting and able to cooperate with eye examinations every six months
Be of stable residency
Have both eyes and respective lenses in tact
Female volunteers must use a reliable method of birth control

Study Participants Will Receive

All study-related evaluations, physical exams and visits at no cost
All study medication at no cost
Possible compensation for their time and travel

Location

Richmond Behavioral Associates

4349 Hylan Boulevard Staten Island, NY 10312

Call to schedule a screening

(718) 317-5522 ext 3

Schizophrenia Clinical Trial

Schizophrenia Clinical Trial